Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that the U.S. Food and Drug Administration (FDA) has approved ROMVIMZA™ (vimseltinib), a kinase ...
Donald Chew’s new book looks at how certain ideas made the US the most successful nation at generating wealth, if not ...
Fifth Subject in BB-301 Phase 1b/2a Clinical Treatment Study safely treated in February 2025--Interim clinical study update to be presented in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback